UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Link zum Volltext

Verfügbarkeit prüfen

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

Journal of hypertension, 2007-04, Vol.25 (4), p.891-894

2007

Link zum Volltext

Verfügbarkeit prüfen

Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension

Hypertension (Dallas, Tex. 1979), 2011-03, Vol.57 (3), p.490-496

2011

Link zum Volltext

Verfügbarkeit prüfen

For Debate: The 2023 European Society of Hypertension guidelines - cause for concern

Journal of hypertension, 2024-06, Vol.42 (6), p.948

2024

Link zum Volltext

Verfügbarkeit prüfen

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in Hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

American journal of hypertension, 2004-09, Vol.17 (9), p.764-769

2004

Link zum Volltext

Verfügbarkeit prüfen

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Journal of hypertension, 2002-09, Vol.20 (9), p.1879-1886

2002

Link zum Volltext

Verfügbarkeit prüfen

Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies

Journal of hypertension, 2011-02, Vol.29 (2), p.396-399

2011

Link zum Volltext

Verfügbarkeit prüfen

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Link zum Volltext

Verfügbarkeit prüfen

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry

Journal of hypertension, 2017-11, Vol.35 (11), p.2310-2314

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessment of platelet activation indices using the ADVIA™ 120 amongst 'high-risk' patients with hypertension

Annals of medicine (Helsinki), 2007, Vol.39 (1), p.72-78

2007

Link zum Volltext

Verfügbarkeit prüfen

Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety

Psychosomatic medicine, 2001-03, Vol.63 (2), p.221

2001

Link zum Volltext

Verfügbarkeit prüfen

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Journal of hypertension, 2001-06, Vol.19 (6), p.1139-1147

2001

Link zum Volltext

Verfügbarkeit prüfen

Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor

Clinical research in cardiology, 2011-06, Vol.100 (6), p.531-537

2011

Link zum Volltext

Verfügbarkeit prüfen

Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project

Hypertension research, 2013-06, Vol.36 (6), p.546-549

2013

Link zum Volltext

Verfügbarkeit prüfen

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations

Annals of internal medicine, 2019-06, Vol.170 (12), p.909

2019

Link zum Volltext

Verfügbarkeit prüfen

Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project

Hypertension research, 2012-07, Vol.35 (7), p.725-728

2012

Link zum Volltext

Verfügbarkeit prüfen

Circulating Endothelial Cells, Arterial Stiffness, and Cardiovascular Risk Stratification in Hypertension

Chest, 2007-11, Vol.132 (5), p.1540-1547

2007

Link zum Volltext

Verfügbarkeit prüfen

The end of β blockers for uncomplicated hypertension?

The Lancet (British edition), 2005-10, Vol.366 (9496), p.1510-1512

Beevers, D Gareth

2005

Link zum Volltext

Verfügbarkeit prüfen

Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension

Angiology, 2012-04, Vol.63 (3), p.194-198

2012

Link zum Volltext

Verfügbarkeit prüfen

Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension

Angiology, 2012-01, Vol.63 (1), p.35-38

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of ambulatory blood pressure monitoring versus clinical blood pressure measurement in the management of hypertension in pregnancy. A feasibility study

Pregnancy hypertension, 2018-01, Vol.11, p.142-144

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving Survival of Malignant Hypertension Patients Over 40 Years

American journal of hypertension, 2009-11, Vol.22 (11), p.1199-1204

2009

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in primary aldosteronism

Journal of the renin-angiotensin-aldosterone system, 2009-12, Vol.10 (4), p.190-194

2009

Link zum Volltext

Verfügbarkeit prüfen

Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Journal of the American College of Cardiology, 2004-07, Vol.44 (2), p.415-422

2004

Link zum Volltext

Verfügbarkeit prüfen

Inter-arm differences in blood pressure: when are they clinically significant?

Journal of hypertension, 2002-06, Vol.20 (6), p.1089-1095

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(226)

Publikationsform

Sprache

Englisch
(266)
Japanisch
(32)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(169)
Life Sciences & Biomedicine
(161)
Science & Technology
(161)
Female
(127)
Male
(113)
Middle Aged
(109)
Biological And Medical Sciences
(108)
Medical Sciences
(108)
Cardiovascular System & Cardiology
(100)
Aged
(77)
Peripheral Vascular Disease
(74)
Adult
(72)
Cardiology. Vascular System
(71)
Hypertension
(61)
Arterial Hypertension. Arterial Hypotension
(56)
Blood And Lymphatic Vessels
(56)
Blood Pressure
(49)
Hypertension - Drug Therapy
(49)
Clinical Manifestations. Epidemiology. Investigative Techniques. Etiology
(46)
Antihypertensive Agents - Therapeutic Use
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension

For Debate: The 2023 European Society of Hypertension guidelines - cause for concern

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in Hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry

Assessment of platelet activation indices using the ADVIA™ 120 amongst 'high-risk' patients with hypertension

Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor

Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project

β-Blocker Use in Pregnancy and the Risk for Congenital Malformations

Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project

Circulating Endothelial Cells, Arterial Stiffness, and Cardiovascular Risk Stratification in Hypertension

The end of β blockers for uncomplicated hypertension?

Angiogenin and Hemoxygenase in Pregnancy: Influence of Hypertension

Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension

A randomized trial of ambulatory blood pressure monitoring versus clinical blood pressure measurement in the management of hypertension in pregnancy. A feasibility study

Improving Survival of Malignant Hypertension Patients Over 40 Years

Atrial fibrillation in primary aldosteronism

Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Inter-arm differences in blood pressure: when are they clinically significant?

Suchergebnisse filtern